Insider Transactions in Q2 2021 at Equillium, Inc. (EQ)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2021
|
Joel Rothman Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,742
+25.19%
|
$15,484
$2.35 P/Share
|
|
Jun 10
2021
|
Jason A Keyes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,535
+23.81%
|
$11,070
$2.35 P/Share
|
|
Jun 10
2021
|
Christine Zedelmayer Sr. Vice President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
9,032
+9.07%
|
$18,064
$2.35 P/Share
|
|
Jun 08
2021
|
Stephen Connelly Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,495
-1.05%
|
$73,465
$7.18 P/Share
|
|
Jun 08
2021
|
Stephen Connelly Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,495
+1.04%
|
$41,980
$4.75 P/Share
|
|
Jun 07
2021
|
Stephen Connelly Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
22,390
-1.11%
|
$156,730
$7.11 P/Share
|
|
Jun 07
2021
|
Stephen Connelly Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,390
+1.1%
|
$67,170
$3.78 P/Share
|
|
Jun 04
2021
|
Stephen Connelly Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
13,539
-0.68%
|
$94,773
$7.01 P/Share
|
|
Jun 04
2021
|
Stephen Connelly Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,539
+0.67%
|
$40,617
$3.78 P/Share
|
|
May 26
2021
|
Jason A Keyes Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
5,000
-4.14%
|
$30,000
$6.5 P/Share
|